{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:37:47Z","timestamp":1794490667687,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T00:00:00Z","timestamp":1645574400000},"content-version":"vor","delay-in-days":387,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008272","name":"Novartis Pharmaceuticals Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000046","name":"Abbott Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["18 CDA 34110215"],"award-info":[{"award-number":["18 CDA 34110215"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014941","name":"Cytokinetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014941","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jacc.2020.12.034","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T01:24:52Z","timestamp":1613438692000},"page":"848-857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction"],"prefix":"10.1016","volume":"77","author":[{"given":"Cian P.","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhaval","family":"Kolte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin F.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason H.","family":"Wasfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.12.034_bib1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1001\/jama.1939.02800170021007","article-title":"Acute myocardial infarction not due to coronary artery occlusion","volume":"112","author":"Friedberg","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.12.034_bib2","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/CIRCULATIONAHA.107.187397","article-title":"Universal definition of myocardial infarction","volume":"116","author":"Thygesen","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.034_bib3","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.034_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/heartjnl-2016-310243","article-title":"Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury","volume":"103","author":"Cediel","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.jacc.2020.12.034_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.amjmed.2013.02.029","article-title":"Classification of myocardial infarction: frequency and features of type 2 myocardial infarction","volume":"126","author":"Saaby","year":"2013","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.12.034_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084285","article-title":"Type-II myocardial infarction\u2014patient characteristics, management and outcomes","volume":"9","author":"Stein","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jacc.2020.12.034_bib7","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1161\/CIRCULATIONAHA.117.031806","article-title":"Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury","volume":"137","author":"Chapman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.034_bib8","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MCA.0000000000000545","article-title":"Treatment and outcomes of type 2 myocardial infarction and myocardial injury compared with type 1 myocardial infarction","volume":"29","author":"Smilowitz","year":"2018","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacc.2020.12.034_bib9","article-title":"Impact of type 2 myocardial infarction (MI) on hospital-level MI outcomes: implications for quality and public reporting","volume":"7","author":"Arora","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.12.034_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000017404","article-title":"Type 2 myocardial infarction in general medical wards: Clinical features, treatment, and prognosis in comparison with type 1 myocardial infarction","volume":"98","author":"Furie","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jacc.2020.12.034_bib12","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.amjmed.2017.05.049","article-title":"Type 1 and 2 myocardial infarction and myocardial injury: clinical transition to high-sensitivity cardiac troponin I","volume":"130","author":"Sandoval","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.12.034_bib13","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/acem.13033","article-title":"Causes of elevated cardiac troponins in the emergency department and their associated mortality","volume":"23","author":"Meigher","year":"2016","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.jacc.2020.12.034_bib14","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.jacc.2017.07.774","article-title":"Effect of definition on incidence and prognosis of type 2 myocardial infarction","volume":"70","author":"Nestelberger","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.034_bib15","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1093\/eurheartj\/ehx457","article-title":"Discrimination of patients with type 2 myocardial infarction","volume":"38","author":"Neumann","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.12.034_bib16","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.amjmed.2015.11.006","article-title":"Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins","volume":"129","author":"Sarkisian","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.12.034_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijcard.2008.10.021","article-title":"The impact of the 2007 ESC-ACC-AHA-WHF Universal definition on the incidence and classification of acute myocardial infarction: a retrospective cohort study","volume":"139","author":"Melberg","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jacc.2020.12.034_bib18","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1161\/CIRCULATIONAHA.116.023052","article-title":"Incident type 2 myocardial infarction in a cohort of patients undergoing coronary or peripheral arterial angiography","volume":"135","author":"Gaggin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.034_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jacc.2020.12.034_bib20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/ajh\/hpx048","article-title":"Trends in hospitalization for hypertensive emergency, and relationship of end-organ damage with in-hospital mortality","volume":"30","author":"Shah","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.jacc.2020.12.034_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/CIRCULATIONAHA.119.043100","article-title":"Incidence, trends, and outcomes of type 2 myocardial infarction in a community cohort","volume":"141","author":"Raphael","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.12.034_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jamacardio.2019.0716","article-title":"Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs","volume":"4","author":"McCarthy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacc.2020.12.034_bib23","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jacc.2018.06.055","article-title":"Type 2 myocardial infarction and the hospital readmission reduction program","volume":"72","author":"McCarthy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.034_bib24","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.amjmed.2019.02.037","article-title":"Type 2 myocardial infarction and value-based programs: cutting the supply in the absence of demand","volume":"132","author":"McCarthy","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jacc.2020.12.034_bib25","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.jacc.2018.10.015","article-title":"Translating the translation","volume":"72","author":"Valentine","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.12.034_bib26","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/KP.a2013.0284","article-title":"Clinical characteristics, aetiology and occurrence of type 2 acute myocardial infarction","volume":"72","author":"Szyma\u0144ski","year":"2014","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jacc.2020.12.034_bib27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.amjmed.2014.10.056","article-title":"Sensitive troponin assay and the classification of myocardial infarction","volume":"128","author":"Shah","year":"2015","journal-title":"Am J Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720381389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720381389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:38:14Z","timestamp":1760017094000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720381389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0735109720381389"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.034","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739556098.793583558","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}